Damora Therapeutics, Inc. (DMRA)
NASDAQ: DMRA · Real-Time Price · USD
20.16
-0.49 (-2.40%)
Oct 5, 2026, 9:59 AM EDT - Market open
Damora Therapeutics Market Cap
Damora Therapeutics has a market cap or net worth of $1.24 billion as of October 5, 2026. Its market cap has increased by 24,686.04% in one year.
Market Cap
1.24B
Enterprise Value
703.76M
1-Year Change
24,686.04%
Ranking
Category
Stock Price
$20.16
ChartMarket Cap Chart
Since October 29, 2020, Damora Therapeutics's market cap has increased from $368.78M to $1.24B, an increase of 237.41%. That is a compound annual growth rate of 22.73%.
| Date | Market Cap | % Change |
|---|---|---|
| Oct 5, 2026 | 1.24B | 3,285.39% |
| Dec 31, 2025 | 36.75M | 500.17% |
| Dec 31, 2024 | 6.12M | -68.63% |
| Dec 29, 2023 | 19.52M | -33.64% |
| Dec 30, 2022 | 29.42M | -61.57% |
| Dec 31, 2021 | 76.54M | -75.78% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Oct 29, 2020 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Alpha Tau Medical | 1.36B |
| Omeros | 1.35B |
| Kailera Therapeutics | 1.35B |
| Nanobiotix | 1.31B |
| ORIC Pharmaceuticals | 1.27B |
| Avalyn Pharma | 1.25B |
| Replimune Group | 1.23B |
| Savara | 1.22B |